From Nasdaq:

The European Commission has stated that Amazon has not offered any remedies to address concerns over its $1.4 billion acquisition of iRobot. The absence of remedies could mean either unconditional EU antitrust approval or an EU veto of the deal, according to the update on the European Commission website.

Initially, Amazon was set to win unconditional EU clearance for the deal after the Commission’s lawyers disagreed with the warning. The lawyers later dropped their objections to such a charge sheet, known as a statement of objections. Now, the absence of remedies could swing the decision either way for Amazon’s acquisition of iRobot.



Read more: Amazon has not offered remedies to EU concerns over iRobot deal